Search Results - Stanislas Pol
- Showing 1 - 20 results of 22
- Go to Next Page
-
1
HCV: is mission accomplished? The pros by Stanislas Pol
Published in Journal of Virus Eradication (2016-05-01)Get full text
Article -
2
-
3
Inhibition of DPP4 activity in humans establishes its in vivo role in CXCL10 post‐translational modification: prospective placebo‐controlled clinical studies by Jérémie Decalf, Kristin V Tarbell, Armanda Casrouge, Jeffrey D Price, Grace Linder, Estelle Mottez, Philippe Sultanik, Vincent Mallet, Stanislas Pol, Darragh Duffy, Matthew L Albert
Published in EMBO Molecular Medicine (2016-04-01)Get full text
Article -
4
Antiviral Treatment of HCV-Infected Patients with B-Cell Non-Hodgkin Lymphoma: ANRS HC-13 Lympho-C Study. by Laurent Alric, Caroline Besson, Nathanael Lapidus, Juliette Jeannel, Jean-Marie Michot, Patrice Cacoub, Danielle Canioni, Stanislas Pol, Frédéric Davi, Pascaline Rabiega, Loic Ysebaert, Delphine Bonnet, Olivier Hermine
Published in PLoS ONE (2016-01-01)Get full text
Article -
5
Cystic fibrosis liver disease progression in the era of elexacaftor–tezacaftor–ivacaftor by Charlotte Mouliade, Lucia Parlati, Stylianos Tzedakis, Mathis Collier, Samir Bouam, Anais Vallet-Pichard, Valérie D’Halluin-Venier, Reem Kanaan, Stanislas Pol, Philippe Sogni, Pierre-Régis Burgel, Vincent Mallet
Published in JHEP Reports (2025-10-01)Get full text
Article -
6
External Validation of LCR1-LCR2, a Multivariable Hepatocellular Carcinoma Risk Calculator, in a Multiethnic Cohort of Patients With Chronic Hepatitis B by Thierry Poynard, Jean Marc Lacombe, Olivier Deckmyn, Valentina Peta, Sepideh Akhavan, Fabien Zoulim, Victor de Ledinghen, Didier Samuel, Philippe Mathurin, Vlad Ratziu, Dominique Thabut, Chantal Housset, Hélène Fontaine, Stanislas Pol, Fabrice Carrat
Published in Gastro Hep Advances (2022-01-01)Get full text
Article -
7
Unknown Circovirus in Immunosuppressed Patient with Hepatitis, France, 2022 by Christophe Rodriguez, Laure Boizeau, Alexandre Soulier, Melissa N’Debi, Vanessa Demontant, Elisabeth Trawinski, Sarah Seng, Hélène Fontaine, Paul-Louis Woerther, Sarah Marchand, Slim Fourati, Stéphane Chevaliez, Pierre Cappy, Stanislas Pol, Jean-Michel Pawlotsky
Published in Emerging Infectious Diseases (2023-05-01)Get full text
Article -
8
An in vitro diagnostic certified point of care single nucleotide test for IL28B polymorphisms. by Darragh Duffy, Estelle Mottez, Shaun Ainsworth, Tan-Phuc Buivan, Aurelie Baudin, Muriel Vray, Ben Reed, Arnaud Fontanet, Alexandra Rohel, Ventzislava Petrov-Sanchez, Laurent Abel, Ioannis Theodorou, Gino Miele, Stanislas Pol, Matthew L Albert
Published in PLoS ONE (2017-01-01)Get full text
Article -
9
Factors associated with high costs of patients with metabolic dysfunction-associated steatotic liver disease: an observational study using the French CONSTANCES cohort by Arnaud Nze Ossima, Angélique Brzustowski, Valérie Paradis, Bernard Van Beers, Catherine Postic, Cédric Laouénan, Stanislas Pol, Laurent Castéra, Jean-François Gautier, Sebastien Czernichow, Anais Vallet-Pichard, Etienne Larger, Lawrence Serfaty, Marie Zins, Dominique Valla, Isabelle Durand Zaleski
Published in Clinical Diabetes and Endocrinology (2024-04-01)Get full text
Article -
10
Mortality risk in migrant and non-migrant individuals with chronic hepatitis B virus infection: a French hospital-based cohort study (ANRS CO22 HEPATHER) by Marta Lotto, Clémence Ramier, Fabrice Carrat, Lauren Périères, Elisabeth Delaroque-Astagneau, Jérôme Nicol, Fabienne Marcellin, Fabien Zoulim, Vincent Di Beo, Mathilde Bertheau, Stanislas Pol, Camelia Protopopescu, Marc Bourlière, Patrizia Carrieri, the ANRS/AFEF CO22 HEPATHER Study Group
Published in BMC Global and Public Health (2025-07-01)Get full text
Article -
11
Cannabis use as a factor of lower corpulence in hepatitis C-infected patients: results from the ANRS CO22 Hepather cohort by Tangui Barré, Fabrice Carrat, Clémence Ramier, Hélène Fontaine, Vincent Di Beo, Morgane Bureau, Céline Dorival, Dominique Larrey, Elisabeth Delarocque-Astagneau, Philippe Mathurin, Fabienne Marcellin, Ventzislava Petrov-Sanchez, Carole Cagnot, Patrizia Carrieri, Stanislas Pol, Camelia Protopopescu, the ANRS/AFEF Hepather study group
Published in Journal of Cannabis Research (2022-06-01)Get full text
Article -
12
Late presentation of chronic viral hepatitis for medical care: a consensus definition by Stefan Mauss, Stanislas Pol, Maria Buti, Erika Duffell, Charles Gore, Jeffrey V. Lazarus, Hilje Logtenberg-van der Grient, Jens Lundgren, Antons Mozalevskis, Dorthe Raben, Eberhard Schatz, Stefan Wiktor, Jürgen K. Rockstroh, on behalf of the European consensus working group on late presentation for Viral Hepatitis Care
Published in BMC Medicine (2017-05-01)Get full text
Article -
13
Safety and immunogenicity of the therapeutic vaccine TG1050 in chronic hepatitis B patients: a phase 1b placebo-controlled trial by Fabien Zoulim, Claire Fournier, François Habersetzer, Martin Sprinzl, Stanislas Pol, Carla S Coffin, Vincent Leroy, Mang Ma, Heiner Wedemeyer, Ansgar W Lohse, Robert Thimme, Karine Lugardon, Perrine Martin, Bérangère Bastien, Benoit Sansas, Nathalie Adda, Celine Halluard, Kaïdre Bendjama, Maud Brandely, Geneviève Inchauspé
Published in Human Vaccines & Immunotherapeutics (2020-02-01)Get full text
Article -
14
Effect of Peg-IFN on the viral kinetics of patients with HDV infection treated with bulevirtide by Selma El Messaoudi, Ségolène Brichler, Claire Fougerou-Leurent, Emmanuel Gordien, Athenaïs Gerber, Amal Kortebi, Garance Lagadic, Miroslava Subic-Levrero, Sophie Metivier, Stanislas Pol, Anne Minello, Vlad Ratziu, Vincent Leroy, Philippe Mathurin, Laurent Alric, Fatoumata Coulibaly, Jean-Michel Pawlotsky, Fabien Zoulim, Victor de Lédinghen, Jérémie Guedj
Published in JHEP Reports (2024-08-01)Get full text
Article -
15
Metabolic Disorders in Patients with Chronic Hepatitis B Virus Infection: Coffee as a Panacea? (ANRS CO22 Hepather Cohort) by Tangui Barré, Hélène Fontaine, Stanislas Pol, Clémence Ramier, Vincent Di Beo, Camelia Protopopescu, Fabienne Marcellin, Morgane Bureau, Marc Bourlière, Céline Dorival, Ventzislava Petrov-Sanchez, Tarik Asselah, Elisabeth Delarocque-Astagneau, Dominique Larrey, Jean-Charles Duclos-Vallée, Fabrice Carrat, Patrizia Carrieri, on behalf of the ANRS/AFEF Hepather Study Group
Published in Antioxidants (2022-02-01)Get full text
Article -
16
Patient and physician expectations regarding disease and treatment of advanced HCC: The prospective PERCEPTION1 study by Jean-Charles Nault, Nanthara Sritharan, Gontran Verset, Ivan Borbath, Marie Lequoy, Manon Allaire, Hélène Regnault, Isabelle Colle, Hans Orlent, Isabelle Sinapi, Christophe Moreno, Edouard Larrey, Sabrina Sidali, Clémence Hollande, Giuliana Amaddeo, Stanislas Pol, Pierre Nahon, Nathalie Ganne-Carrié, Vincent Levy, Coralie Bloch-Queyrat, Eric Trepo, Mohammed Bouattour
Published in JHEP Reports (2024-11-01)Get full text
Article -
17
Impact of IL28B, APOH and ITPA Polymorphisms on Efficacy and Safety of TVR- or BOC-Based Triple Therapy in Treatment-Experienced HCV-1 Patients with Compensated Cirrhosis from the... by Frédégonde About, Tiphaine Oudot-Mellakh, Jonathan Niay, Pascaline Rabiéga, Vincent Pedergnana, Darragh Duffy, Philippe Sultanik, Carole Cagnot, Fabrice Carrat, Patrick Marcellin, Fabien Zoulim, Dominique Larrey, Christophe Hézode, Hélène Fontaine, Jean-Pierre Bronowicki, Stanislas Pol, Matthew L Albert, Ioannis Theodorou, Aurélie Cobat, Laurent Abel, ANRS CO20-CUPIC study group
Published in PLoS ONE (2015-01-01)Get full text
Article -
18
Bystander hyperactivation of preimmune CD8+ T cells in chronic HCV patients by Cécile Alanio, Francesco Nicoli, Philippe Sultanik, Tobias Flecken, Brieuc Perot, Darragh Duffy, Elisabetta Bianchi, Annick Lim, Emmanuel Clave, Marit M van Buuren, Aurélie Schnuriger, Kerstin Johnsson, Jeremy Boussier, Antoine Garbarg-Chenon, Laurence Bousquet, Estelle Mottez, Ton N Schumacher, Antoine Toubert, Victor Appay, Farhad Heshmati, Robert Thimme, Stanislas Pol, Vincent Mallet, Matthew L Albert
Published in eLife (2015-11-01)Get full text
Article -
19
In Situ Hepatitis C NS3 Protein Detection Is Associated with High Grade Features in Hepatitis C-Associated B-Cell Non-Hodgkin Lymphomas. by Danielle Canioni, Jean-Marie Michot, Pascaline Rabiega, Thierry J Molina, Frédéric Charlotte, Thierry Lazure, Frédéric Davi, Catherine Settegrana, Françoise Berger, Laurent Alric, Patrice Cacoub, Benjamin Terrier, Felipe Suarez, David Sibon, Jehan Dupuis, Cyrille Feray, Hervé Tilly, Stanislas Pol, Bénédicte Deau Fischer, Sandrine Roulland, Catherine Thieblemont, Véronique Leblond, Fabrice Carrat, Olivier Hermine, Caroline Besson, national ANRS HC13 LymphoC study
Published in PLoS ONE (2016-01-01)Get full text
Article -
20
Impact of COVID-19 on the management of hepatocellular carcinoma in a high-prevalence area: What's new 12 months later? by Raffaele Brustia, Mohamed Bouattour, Manon Allaire, Marie Lequoy, Clémence Hollande, Hélène Regnault, Lorraine Blaise, Nathalie Ganne-Carrié, Valérie Vilgrain, Edouard Larrey, Chetana Lim, Olivier Scatton, Sanaa El Mouhadi, Violaine Ozenne, François Paye, Pierre Balladur, Anthony Dohan, Pierre-Philippe Massault, Stanislas Pol, Marco Dioguardi Burgio, Ailton Sepulveda, Francois Cauchy, Alain Luciani, Daniele Sommacale, Vincent Leroy, Julien Calderaro, Francoise Roudot-Thoraval, Jean-Charles Nault, Giuliana Amaddeo
Published in Annals of Hepatology (2023-11-01)Get full text
Article
